These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 39135956)
41. Prognostic significance of ferroptosis-related genes and their methylation in AML. Zhou F; Chen B Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073 [TBL] [Abstract][Full Text] [Related]
42. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730 [TBL] [Abstract][Full Text] [Related]
43. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment. Chen Y; Qiu X; Liu R BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491 [TBL] [Abstract][Full Text] [Related]
44. Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma. Bai X; Lu F; Li S; Zhao Z; Wang N; Zhao Y; Ma G; Zhang F; Su X; Wang D; Ye J; Li P; Ji C Sci Rep; 2024 Jun; 14(1):12926. PubMed ID: 38839842 [TBL] [Abstract][Full Text] [Related]
45. Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemia. Chen J; Hou Q; Chang T; Zheng J; Yao C; He J; Chen S; Wu X; Jin Z Int J Med Sci; 2024; 21(8):1438-1446. PubMed ID: 38903927 [No Abstract] [Full Text] [Related]
46. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia. Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102 [TBL] [Abstract][Full Text] [Related]
47. A novel immune-related gene signature correlated with serum IL33 expression in acute myeloid leukemia prognosis. Xie JY; Wang WJ; Wang N; Dong Q; Han H; Feng YP; Yuan Y; Feng J; Chen K Am J Transl Res; 2023; 15(6):4332-4344. PubMed ID: 37434810 [TBL] [Abstract][Full Text] [Related]
48. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
49. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000 [TBL] [Abstract][Full Text] [Related]
50. Bioinformatics analysis of the endoplasmic reticulum stress-related prognostic model and immune cell infiltration in acute myeloid leukemia. Pan M; Zhou J; Jiao C; Ge J Hematology; 2023 Dec; 28(1):2221101. PubMed ID: 37294065 [TBL] [Abstract][Full Text] [Related]
51. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
52. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis. Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875 [TBL] [Abstract][Full Text] [Related]
53. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia. Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078 [TBL] [Abstract][Full Text] [Related]
54. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia. Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W Front Immunol; 2022; 13():1038570. PubMed ID: 36544784 [TBL] [Abstract][Full Text] [Related]
55. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia. Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923 [TBL] [Abstract][Full Text] [Related]
56. A CD8 Li Z; Jin P; Xiang R; Li X; Shen J; He M; Liu X; Zhu H; Wu S; Dong F; Zhao H; Liu H; Jin Z; Li J Front Immunol; 2024; 15():1408109. PubMed ID: 39346926 [TBL] [Abstract][Full Text] [Related]
57. Identification of two key biomarkers CD93 and FGL2 associated with survival of acute myeloid leukaemia by weighted gene co-expression network analysis. Han H; Liu J; Zhu S; Zhao T J Cell Mol Med; 2024 Jul; 28(14):e18552. PubMed ID: 39054581 [TBL] [Abstract][Full Text] [Related]
58. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes. Zhao X; Li Y; Wu H Int J Mol Med; 2018 Sep; 42(3):1495-1507. PubMed ID: 29956722 [TBL] [Abstract][Full Text] [Related]
59. A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia. Liu X; Wang L; Kang Q; Feng C; Wang J Front Pharmacol; 2024; 15():1339465. PubMed ID: 38482057 [No Abstract] [Full Text] [Related]
60. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia. Shao R; Wang H; Liu W; Wang J; Lu S; Tang H; Lu Y J Cell Mol Med; 2021 Dec; 25(23):10950-10960. PubMed ID: 34741393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]